Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-19
1997-02-11
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548486, A61K 3140, C07D20912
Patent
active
056021690
ABSTRACT:
There is provided novel substituted 3-phenyl oxindole derivatives of the formula ##STR1## wherein
REFERENCES:
patent: 4542148 (1985-09-01), Kuch et al.
patent: 4614739 (1986-09-01), Kuch et al.
patent: 5200422 (1993-04-01), Olesen et al.
patent: 5373019 (1994-12-01), Zilch et al.
Cook, N. S. Trends in Pharmacol. Sciences (1988), 9, 21.
Singer, J. et al., Pflugers Archiv. (1987) 408, 98.
Baro, I., et al., Pflugers Archiv. (1989) 414 (Suppl. 1), S168.
Laurent, F. et al., Br. J. Pharmacol. 1993 108, 622-626.
Koh, D-S., et al., Neuroscience Lett. (1994) 165, 167-170.
Olesen, et al., European J. Pharmacol., 251, 53-59 (1994).
Quast, U., et al., Trends in Pharmacol Sciences (1989) 10, 431.
Ahmed, F., et al., Br. J. Pharmacol (1984) 83, 227.
Gribkoff Valentin K.
Hewawasam Piyasena
Meanwell Nicholas A.
Algieri Aldo A.
Bristol--Myers Squibb Company
McKane Joseph
LandOfFree
3-substituted oxindole derivatives as potassium channel modulato does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-substituted oxindole derivatives as potassium channel modulato, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted oxindole derivatives as potassium channel modulato will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342622